Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Daniel Lau

Registered Nurse, Psychiatric/Mental Health Toledo, OH Nurse Practitioner

NPI 1225587090 CMS profile 10678726

1425 Starr Ave, Toledo, OH 43605

Open in the dashboard

General payments

$6,289

317 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Lau of Toledo, OH is reported in the CMS Open Payments database as having received $6,289 across 317 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Registered Nurse, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $554 49
2024 General $660 25
2023 General $2,071 106
2022 General $1,678 73
2021 General $1,326 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Lau
  • Registered Nurse, Psychiatric/Mental Health median
  • Middle half of Registered Nurse, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Daniel Lau were reported at $554. Among 280 Registered Nurse, Psychiatric/Mental Health profiles paid that year, the median was $140 and the middle half received between $43 and $515.

Show as a table
Year Daniel Lau Registered Nurse, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,326 $101 $31–$244 $132
2022 $1,678 $103 $36–$248 $149
2023 $2,071 $138 $45–$382 $160
2024 $660 $167 $39–$462 $164
2025 $554 $140 $43–$515 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Alkermes, Inc. $1,139 44 payments
  2. AbbVie, Inc. $1,012 35 payments
  3. Indivior Inc. $831 76 payments
  4. Otsuka America Pharmaceutical, Inc. $670 40 payments
  5. ITI, Inc. $429 22 payments
  6. Teva Pharmaceuticals USA, Inc. $353 19 payments
  7. Axsome Therapeutics, Inc. $315 13 payments
  8. Janssen Pharmaceuticals, Inc $239 9 payments
  9. Braeburn Inc. $234 2 payments
  10. Sunovion Pharmaceuticals Inc. $153 10 payments
  11. Other $913 47 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,213 313 payments
  2. Education $75 4 payments
Products named General payments · program years 2021–2025
  1. VRAYLAR $994 34 payments
  2. LYBALVI Cns $761 30 payments
  3. ARISTADA Cns $670 31 payments
  4. ARISTADA Cns $670 31 payments
  5. SUBLOCADE $579 61 payments
  6. LYBALVI Cns $529 18 payments
  7. REXULTI $505 31 payments
  8. ARISTADA INITIO $438 19 payments
  9. ABILIFY MAINTENA $429 26 payments
  10. CAPLYTA $429 22 payments
  11. Other $4,585 179 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

123

Median for Registered Nurse: 109

Drug cost

$13,328

Median for Registered Nurse: $4,454

Branded share of claims

33.3%

Median for Registered Nurse: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 20 $11,882
Albuterol Sulfate Hfa Albuterol Sulfate Brand 21 $750
Atorvastatin Calcium Generic 18 $217
Amlodipine Besylate Generic 22 $161
Levothyroxine Sodium Generic 13 $127
Omeprazole Generic 15 $97
Donepezil Hcl Generic 14 $93

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 476 Part D prescribers listed as Registered Nurse; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 8 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SUBLOCADE
  • Indivior Inc. $200
$200 — —
VRAYLAR
  • AbbVie, Inc. $150
$150 — —
BRIXADI
  • Braeburn Inc. $121
$121 — —
Austedo XR
  • Teva Pharmaceuticals USA, Inc. $88
$88 — —
CAPLYTA
  • ITI, Inc. $37
$37 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 8 in the dashboard with a free account

Records

317 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Registered Nurse, Psychiatric/Mental Health in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record